MedTrace Logo

Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients

NCT01043250 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2011-07-25

No results posted yet for this study

Summary

In this study, we are going to investigate quantitative and qualitative natures of appetite and eating-behavior changes induced by atypical antipsychotics, i.e., risperidone, olanzapine and aripiprazole, in schizophrenia patients.

Conditions

Sponsors & Collaborators

  • Ministry of Health & Welfare, Korea

    collaborator OTHER_GOV

  • Korea Otsuka Pharmaceutical Co., Ltd.

    collaborator INDUSTRY

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Kyung Sue Hong, MD · Samsung Medical Center

Eligibility

Min Age
19 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2010-04-30
Completion
2010-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01043250 on ClinicalTrials.gov